639 filings
Page 5 of 32
8-K
a5oj8 ufe1m
9 Aug 21
Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates
5:04pm
8-K
3q5h sgjs
21 May 21
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting
4:01pm
8-K
k8f sfhuuc
13 May 21
Departure of Directors or Certain Officers
4:31pm
8-K
htopquv1i1w
6 May 21
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:17pm
8-K
pahq0vt
9 Apr 21
Departure of Directors or Certain Officers
8:45am
DEFA14A
4vbhd
7 Apr 21
Additional proxy soliciting materials
8:49am
8-K
n7l24 hkeoxj918c4
25 Mar 21
Departure of Directors or Certain Officers
12:00am
SEC STAFF
3kzsgyk854
11 Mar 21
SEC staff action: Order
12:00am
8-K
mbe q78hgih2cqr0
2 Mar 21
Departure of Directors or Certain Officers
4:01pm
8-K
oj99n 3d0o3rb
25 Feb 21
Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
fn4w3gj2kq4pws
23 Feb 21
Departure of Directors or Certain Officers
4:09pm
SEC STAFF
rxtcm86
10 Feb 21
SEC staff action: Order
12:00am
8-K
bzrx8fpkk
5 Feb 21
Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors
9:12am
8-K
seeky1q01 05d8rnq
14 Jan 21
Regulation FD Disclosure
8:21am
8-K
zqgb78gctquia54ea514
30 Dec 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
b92gbi
18 Dec 20
Ziopharm Comments on Consent Solicitation Results
8:31am